H Onodera Selected Research

H Onodera Research Topics

Disease

14	Neoplasms (Cancer) 01/2006 - 01/2000
6	Carcinogenesis 08/2001 - 07/2000
5	Adenoma (Adenomas) 08/2001 - 04/2000
5	Carcinoma (Carcinomatosis) 08/2001 - 04/2000
4	Colorectal Neoplasms (Colorectal Cancer) 04/2001 - 01/2000
3	Hyperplasia 05/2001 - 11/2000
2	Body Weight (Weight, Body) 01/2006 - 11/2000
2	Atrophy 01/2004 - 09/2000
2	Muscle Weakness 01/2003 - 02/2000
2	Myasthenia Gravis 08/2001 - 04/2001
1	Heart Failure 08/2018
1	Heart Diseases (Heart Disease) 08/2018
1	Cardiomyopathies (Cardiomyopathy) 08/2018
1	Collagenous Colitis 01/2010
1	Sudden Death 05/2007
1	Airway Obstruction (Choking) 05/2007
1	Central Sleep Apnea (Central Sleep Apnea Syndrome) 05/2007
1	Apnea 05/2007
1	Multiple System Atrophy 05/2007
1	Sleep Apnea Syndromes (Sleep Apnea) 05/2007
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2003
1	Seizures (Absence Seizure) 01/2003
1	Intellectual Disability (Idiocy) 01/2003
1	Hyperalgesia 10/2001
1	Pain (Aches) 10/2001
1	Neuralgia (Stump Neuralgia) 10/2001
1	Cardiac Arrhythmias (Arrythmia) 04/2001
1	Paralysis (Palsy) 04/2001
1	Disease Progression 04/2001
1	Multiple Sclerosis 03/2001
1	Adenocarcinoma 11/2000
1	Ulcerative Colitis 08/2000
1	Pulmonary Edema 05/2000
1	Endometrial Stromal Sarcoma 05/2000
1	Hydrothorax 05/2000
1	Hypertrophy 05/2000
1	Lymphoma (Lymphomas) 05/2000

Drug/Important Bio-Agent (IBA)

4	diisopropanolnitrosamineIBA 05/2001 - 09/2000
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2001 - 09/2000
3	Messenger RNA (mRNA)IBA 04/2001 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 04/2001 - 01/2000
2	Indicators and Reagents (Reagents)IBA 08/2018 - 01/2000
2	Xylazine (Xylazin)IBA 04/2001 - 05/2000
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 11/2000 - 05/2000
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2000 - 01/2000
1	Atrial Natriuretic Factor (ANF)IBA 08/2018
1	Lansoprazole (Prevacid)FDA LinkGeneric 01/2010
1	Ammonium SulfateIBA 01/2006
1	Testosterone (Sustanon)FDA Link 01/2004
1	GABA AntagonistsIBA 01/2003
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2003
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2003
1	DystrophinIBA 01/2003
1	Kainic Acid (Kainate)IBA 01/2003
1	Dinoprostone (PGE2)FDA Link 10/2001
1	EugenolIBA 08/2001
1	Urethane (Ethyl Carbamate)IBA 08/2001
1	SmokeIBA 08/2001
1	2,6-xylidineIBA 05/2001
1	NitrosaminesIBA 05/2001
1	kojic acidIBA 05/2001
1	Caspase 3 (Caspase-3)IBA 04/2001
1	IodineIBA 04/2001
1	human MMP12 proteinIBA 04/2001
1	Acetazolamide (Diamox)FDA LinkGeneric 04/2001
1	Hormones (Hormone)IBA 04/2001
1	Hypnotics and Sedatives (Sedatives)IBA 04/2001
1	Imipramine (Janimine)FDA LinkGeneric 04/2001
1	PlasminogenIBA 04/2001
1	PotassiumIBA 04/2001
1	AngiostatinsIBA 04/2001
1	Matrix Metalloproteinase 12IBA 04/2001
1	Chemokine ReceptorsIBA 03/2001
1	ChemokinesIBA 03/2001
1	Methoxychlor (Metox)IBA 11/2000
1	Endocrine DisruptorsIBA 11/2000
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2000
1	Nitrofurazone (Nitrofural)FDA Link 09/2000
1	GonadotropinsIBA 09/2000
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2000
1	Gap Junction beta-1 ProteinIBA 07/2000
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2000
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2000
1	beta-NaphthoflavoneIBA 07/2000
1	TransferasesIBA 06/2000
1	ParaffinIBA 06/2000
1	Biotin (Vitamin H)FDA Link 06/2000
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 06/2000
1	deoxyuridine triphosphateIBA 06/2000
1	Phenolphthalein (Modane)IBA 05/2000
1	Codon (Codons)IBA 05/2000
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2000
1	LyasesIBA 04/2000
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2000
1	MED 27IBA 04/2000

Therapy/Procedure

2	Oral Administration 10/2001 - 02/2000
2	Intraperitoneal Injections 08/2001 - 11/2000
1	Tracheostomy 05/2007
1	Thymectomy 08/2001
1	Appendectomy 08/2000